Feature | September 07, 2010| Dave Fornell

Forward-Looking IVUS May Aid CTO Visualization

FL-IVUS has promise to help speed chronic total occlusion procedures

A major issue in treating chronic total occlusions (CTOs) is the lack of angiographic visualization. The flow of blood and contrast is completely blocked, eliminating the ability to navigate the vessel or see where wires are being poked. Not being able to see what you are treating is a big reason why operators do not attempt these lesions.

“All you see is the start and the end of the lesion. It can be very terrifying,” said William Lombardi, M.D., FSCAI, medical director of cardiac cath labs at St. Joseph Hospital, Bellingham, Wash.

In a comparison of items needed to treat CTOs, Scott Huennekens, president and CEO of Volcano Corp., said to build a car you need wheels, steering and headlights. There are already interventional tools available to steer and treat CTOs, but operators still need a way to see where they are driving. “You are always driving in the dark. You have wheels and steering, but you have no headlights, so you can’t see where you are going,” Huennekens said.

Volcano is developing two forward-looking intravascular ultrasound systems (FL-IVUS). One is for visualization ahead of the catheter and the second will incorporate a radio frequency (RF) ablation tip.

Aaron Grantham, M.D., FACC, Mid-America Heart Institute, Kansas City, Mo., is not convinced that incorporating the RF tip will completely solve CTO treatment issues. He said prior RF catheters were unsuccessful. However, he thinks FL-IVUS has the potential to make visualizing and traversing CTOs with wires easier and safer. He is very interested to hear reports about the first-in-man experience scheduled to start this fall in the Netherlands and Chile. “Translation from bench models to bedside will be a major milestone for FL-IVUS,” he said.

Volcano hopes for European CE-mark clearance of its FL-IVUS device by mid-2011, and in the U.S. by the end of 2011. The company said its first-in-man trial for the FL-IVUS ablation system is set to begin by mid-2011.

“In theory, forward-looking IVUS has promise. However, some operators already have a 95 percent success rate, so it will have to show it can do the procedure faster,” Lombardi said. “All technology is going to do is shorten the procedure.”

Related Content

Sponsored Content | Videos | TCT| November 05, 2015
DAIC Editor Dave Fornell offers his choices for the most innovative new interventional cardiovascular technologies pr
Sponsored Content | Videos | TCT| November 05, 2015
Tom Watson, clinical analyst for MDBuyLine, and DAIC Dave Fornell discuss some of the technology trends at the 2015 T
Sponsored Content | Videos | Intravascular Imaging| October 30, 2015
Ziad  Ali, M.D., associate director of translational medicine, Columbia University Medical Center / New York-Presbyte
News | Cath Lab| October 09, 2015
October 9, 2015 — Cardinal Health is launching its expanded portfolio in the cardiova
Infraredx, NIRS, IVUS
News | Intravascular Imaging| September 11, 2015
September, 11, 2015 – Japanese medical vendor Nipro Corp.
Pie Medical Imaging, Frost & Sullivan, technology leadership, CAAS, cardiovascular diagnostics

CAAS MRV is part of Pie Medical Imaging's suite of imaging solutions for quantitative cardiovascular diagnosis and treatment planning. - See more at: http://www.itnonline.com/content/pie-medical-imaging-recognized-innovati...

News | Cardiac Imaging| September 01, 2015
Based on its recent analysis of the cardiovascular image management market, Frost & Sullivan recognizes Pie Medical...
Pie Medical Imaging, CAAS IntraVascular 2.0, OCT, IVUS, NIRS-IVUS
Technology | Intravascular Imaging| August 03, 2015
Pie Medical Imaging announced the release of CAAS IntraVascular 2.0, the dedicated software for analysis of...
St. Jude Medical, OCT, ILUMIEN III, IVUS, angiography, PCI
Feature | Intravascular Imaging| July 10, 2015
St. Jude Medical, Inc. announced the launch of the ILUMIEN III clinical trial on June 30. ILUMIEN III is a prospective...
Ilumien Optis, 3D OCT, 3-D OCT

An OCT 3-D reconstructed image of a coronary vessel cutaway showing a stent and bifurcating vessels.

Feature | Intravascular Imaging| July 02, 2015 | Dave Fornell
Angiography alone for procedural image guidance in the catheterization lab is sometimes not enough, and it is helpful...
Cordis Corp., Cordis Crossing Portfolio, Elitecross, Outback Elite, CTO
Technology | June 10, 2015
Cordis Corp. announced the launch of the new Elitecross support catheter in the United States and Outback Elite re-...
Overlay Init